Lafutidine Completed Phase 3 Trials for Gastroesophageal Reflux Treatment

Back to Lafutidine
IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT00229424
Verification Study on Lafutidine in Mild Reflux Oesophagitis - Double Blind Controlled Study With Famotidine -